Cargando…

Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression

The transition of sessile epithelial cells to a migratory, mesenchymal phenotype is essential for metazoan development and tissue repair, but this program is exploited by tumor cells in order to escape the confines of the primary organ site, evade immunosurveillance, and resist chemo-radiation. In a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yang, Elble, Randolph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773782/
https://www.ncbi.nlm.nih.gov/pubmed/26901232
http://dx.doi.org/10.3390/jcm5020026
_version_ 1782418807143268352
author Yu, Yang
Elble, Randolph C.
author_facet Yu, Yang
Elble, Randolph C.
author_sort Yu, Yang
collection PubMed
description The transition of sessile epithelial cells to a migratory, mesenchymal phenotype is essential for metazoan development and tissue repair, but this program is exploited by tumor cells in order to escape the confines of the primary organ site, evade immunosurveillance, and resist chemo-radiation. In addition, epithelial-to-mesenchymal transition (EMT) confers stem-like properties that increase efficiency of colonization of distant organs. This review evaluates the role of cell–cell junctions in suppressing EMT and maintaining a quiescent epithelium. We discuss the conflicting data on junctional signaling in cancer and recent developments that resolve some of these conflicts. We focus on evidence from breast cancer, but include other organ sites where appropriate. Current and potential strategies for inhibition of EMT are discussed.
format Online
Article
Text
id pubmed-4773782
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-47737822016-03-03 Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression Yu, Yang Elble, Randolph C. J Clin Med Review The transition of sessile epithelial cells to a migratory, mesenchymal phenotype is essential for metazoan development and tissue repair, but this program is exploited by tumor cells in order to escape the confines of the primary organ site, evade immunosurveillance, and resist chemo-radiation. In addition, epithelial-to-mesenchymal transition (EMT) confers stem-like properties that increase efficiency of colonization of distant organs. This review evaluates the role of cell–cell junctions in suppressing EMT and maintaining a quiescent epithelium. We discuss the conflicting data on junctional signaling in cancer and recent developments that resolve some of these conflicts. We focus on evidence from breast cancer, but include other organ sites where appropriate. Current and potential strategies for inhibition of EMT are discussed. MDPI 2016-02-17 /pmc/articles/PMC4773782/ /pubmed/26901232 http://dx.doi.org/10.3390/jcm5020026 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yu, Yang
Elble, Randolph C.
Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression
title Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression
title_full Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression
title_fullStr Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression
title_full_unstemmed Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression
title_short Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression
title_sort homeostatic signaling by cell–cell junctions and its dysregulation during cancer progression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773782/
https://www.ncbi.nlm.nih.gov/pubmed/26901232
http://dx.doi.org/10.3390/jcm5020026
work_keys_str_mv AT yuyang homeostaticsignalingbycellcelljunctionsanditsdysregulationduringcancerprogression
AT elblerandolphc homeostaticsignalingbycellcelljunctionsanditsdysregulationduringcancerprogression